Additionally, PD-L1 overexpression in myeloid cells and PD-1 downregulation in T cells in breast cancer in vivo are two additional ways that MSC-derived exosomes might compromise protective anti-tumour immunity [111]. This evidence concerns the gene CD274 and breast cancer.